Navigation Links
AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2011 Financial Results
Date:3/20/2012

lacebo-controlled efficacy and safety trial in adults following open abdominal surgery.  Approximately 150 adults, randomized 2:1 to active or placebo treatment groups, will be treated for post-operative pain for 48 - 72 hours after randomization.  
  • A second Phase 3 study is planned as an open-label, active-comparator study comparing ARX-01 to the current standard of care, intravenous patient-controlled analgesia, with morphine. The primary endpoint for this study will assess a measure of efficacy, Global Patient Satisfaction over the 48-hour study period, and will compare ratings of "Good" and "Excellent" for Global Patient Satisfaction between the two groups in a non-inferiority comparison.
  • The third and final planned Phase 3 clinical study is a randomized, double-blind, placebo-controlled efficacy and safety study comparing ARX-01 to placebo for post-operative pain control following major joint replacement surgery.

  • Financial OutlookAcelRx anticipates that research and development expenses will increase significantly over the next several quarters as AcelRx seeks to complete Phase 3 clinical development of ARX-01. The development of ARX-04 beyond Phase 2 and initial preparations for Phase 3 are dependent on the identification of sources of additional funding from the USAMRMC or the identification of a partner to support these efforts.  Additionally, AcelRx anticipates modest increases in general and administrative expenses due to costs associated with operating as a public company and expansion of its corporate infrastructure to support ongoing development of its product candidates.

    AcelRx believes its current cash, cash equivalents and investments are sufficient to fund operations into the first quarter of 2013.

    About AcelRx Pharmaceuticals, Inc. Based in Redwood City, CA, AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) i
    '/>"/>

    SOURCE AcelRx Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
    2. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
    3. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
    4. AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting
    5. AcelRx to Present at the Lazard 6th Annual Healthcare Conference
    6. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
    7. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
    8. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
    9. AcelRx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
    10. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results
    11. AcelRx Pharmaceuticals to Present at the JMP Securities Research Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... DUBLIN , Mar. 30, 2015 Research ... announced the addition of the "Eurpoean Automatic ... Fully-Automated), End-User (Pre-Hospitals, Public Access Market, Hospitals, Alternate ... report to their offering. The European ... grow at a CAGR of 10.9% from 2014 ...
    (Date:3/31/2015)...  The efficacy of continuous UV-C disinfection robots versus ... study 1 of ultraviolet (UV) light disinfection systems ... Curtis Donskey , M.D.  The study tested a continuous ... of time from the same point in the room ... surprisingly low pathogen kill rates for the pulsed xenon ...
    (Date:3/31/2015)... 2015 RnRMarketResearch.com adds "Pemphigus ... report of 68 pages with latest updates, data ... The report "Pemphigus - Pipeline Review, H1 2015" ... development for Pemphigus , complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ...
    Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
    ... Saudi Arabia, Nov. 2, 2010 The Saudi Arabian ... has signed an agreement with Varian Medical Systems and ... magnetic resonance-guided radiation therapy (MRgRT™). Under the ... solution that combines IMRIS, unique movable magnetic resonance imaging ...
    ... Quarter 2010 Results and Host Conference... -- POINT RICHMOND, Calif., Nov. 2, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results ...
    Cached Medicine Technology:Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 2Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 3Saudi Arabia's King Abdullah International Research Center Signs With Varian Medical Systems and IMRIS for Future Technology for Use in Radiotherapy 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 2Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 3Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 4Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 5Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 6Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 7Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 8Transcept Pharmaceuticals to Report Third Quarter 2010 Results and Host Conference Call on November 11, 2010 9
    (Date:3/31/2015)... 31, 2015 Students, teachers, and the ... education in a drastically different way as current and ... and training content is being delivered and received. , ... technology in an unprecedented way with education becoming individualized, ... co-founder and CEO, My Mobile University , This ...
    (Date:3/31/2015)... 2015 The Walk a Mile Project, as ... , just kicked off their 3rd research sequence. The ... “ Substantial Equivalence was and is a massive component ... Director at Change The World Films. “We started our ... GMOs even entered our food supply, just to get a ...
    (Date:3/31/2015)... March 31, 2015 Dr. ... by the American Board of Dermatology and fellowship ... research training at the National Cancer Institute of ... his internship in internal medicine at the Emory ... Pennsylvania in Philadelphia. Dr. Li pursued further training ...
    (Date:3/31/2015)... NJ (PRWEB) March 31, 2015 Dr. Russell ... for Advanced Reconstruction. He was recently quoted in an ... caused by lymphatic issues, causing fluid retention and tissue swelling. ... procedure to relieve and / or improve lymphedema symptoms. ... improve or alleviate the symptoms of lymphedema. The goal ...
    (Date:3/31/2015)... Mirada, CA (PRWEB) March 31, 2015 ... treating hip injuries at all of their clinics. Specialties ... or disorders. , For athletes with hip injuries, ... ready to assess and treat the symptoms and underlying ... to provide minimally-invasive care and prevent future damage, while ...
    Breaking Medicine News(10 mins):Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 2Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 3Health News:The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March 4Health News:Healthpointe Now Treating Hip Dislocations, Hip Fractures, Hip Bursitis, and Hip Strains at Locations in Southern California 2
    ... FRIDAY, April 6 (HealthDay News) -- Anxiety improves a ... a new study. Smell is essential to animals ... also trigger powerful emotional responses in humans, the study ... Li of the University of Wisconsin-Madison exposed 14 young ...
    ... the University of California, San Diego and Veterans Affairs ... pressure may increase the risk of cerebrovascular disease (CVD) ... study has been published in the early online edition ... of the June 5 print publication. The findings ...
    ... Calif. An invasive heart test used routinely to ... patients who recently underwent similar, more effective tests, according ... of Medicine. "This adds both risk to the ... the study Ronald Witteles, MD, assistant professor of cardiovascular ...
    ... -- Children with autism who were born either prematurely or ... with autism who were born on time, according to a ... to inflict self-injury, researchers found. Although the reasons their ... may have something to do with what caused the children ...
    ... clock controls many aspects of human behavior and physiology, ... rhythms leads to increased incidence of many diseases, including ... has its own internal timing mechanism, which is controlled ... One of these proteins, called Rev-erb alpha, was thought ...
    ... HealthDay Reporter , THURSDAY, April 5 (HealthDay News) -- ... antibiotics may be just as good as having the ... studies involving hundreds of patients to determine that treatment ... which has been the so-called "gold standard" of care ...
    Cached Medicine News:Health News:Pulse pressure elevation could presage cerebrovascular disease in Alzheimer's patients 2Health News:Invasive heart test being dramatically overused, Stanford study shows 2Health News:Invasive heart test being dramatically overused, Stanford study shows 3Health News:Pregnancy Length May Influence Severity of Autism 2Health News:Coordinating the circadian clock: Molecular pair controls time-keeping and fat metabolism 2Health News:Study Finds Antibiotics Best for Appendicitis 2Health News:Study Finds Antibiotics Best for Appendicitis 3
    Designed for the effective positioning of patients during spinal surgery, the frame gives the surgeon a remarkably simple and versatile surgical tool....
    High temperature loop tip cautery....
    Low temp, micro fine tip, patented Aaron RAM cauteries....
    6 mm, 45 degree upwards, detachable....
    Medicine Products: